Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A1 | P04798 | 5/20 | 0.43 |
| ▸ | CYP1B1 | Q16678 | 5/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.37 |
| ▸ | F9 | P00740 | 3/20 | 0.36 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.36 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.36 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.34 |
| ▸ | PIM3 | Q86V86 | 2/20 | 0.32 |
| ▸ | TNKS | O95271 | 1/20 | 0.32 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | PIM1 | P11309 | 1/20 | 0.31 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | MPI | P34949 | 1/20 | 0.31 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17247165 | 0.96 | CYP1A1 (0.43) | CYP1A1CYP1B1CYP1A2F9ALOX5 | |
| SCHEMBL27335423 | 0.96 | CYP1A1 (0.44) | CYP1A1CYP1B1CYP1A2F9ALOX5 | |
| SCHEMBL17944339 | 0.92 | CYP1A1 (0.43) | CYP1A1CYP1B1CYP1A2F9ALOX5 | |
| SCHEMBL17247183 | 0.91 | CYP1A1 (0.44) | CYP1A1CYP1B1CYP1A2F9ALOX5 | |
| SCHEMBL17246873 | 0.91 | CYP1A1 (0.48) | CYP1A1CYP1B1CYP1A2F9ALOX5 | |
| SCHEMBL27302922 | 0.90 | ALOX5 (0.39) | CYP1A1CYP1B1CYP1A2F9ALOX5 | |
| SCHEMBL17247133 | 0.90 | CYP1A1 (0.42) | CYP1A1CYP1B1CYP1A2F9ALOX5 | |
| SCHEMBL17247141 | 0.89 | CYP1A1 (0.47) | CYP1A1CYP1B1CYP1A2F9ALOX5 | |
| SCHEMBL19082179 | 0.89 | CYP1A1 (0.40) | CYP1A1CYP1B1CYP1A2F9ALOX5 | |
| SCHEMBL17247164 | 0.89 | CYP1A1 (0.42) | CYP1A1CYP1B1CYP1A2F9ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024096410-A1 | ORGANIC LIGHT-EMITTING DEVICE | 주식회사 엘지화학 | 2024-05-10 | — | — | WO | disclosed |
| US-20180208836-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2018-07-26 | — | — | US | disclosed |
| US-20180208836-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2018-07-26 | — | — | US | disclosed |
| US-20180198077-A1 | ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2018-07-12 | — | — | US | disclosed |
| US-20180130968-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2018-05-10 | — | — | US | disclosed |
| US-20180130968-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2018-05-10 | — | — | US | disclosed |
| US-9947879-B2 | Anthracene derivative and organic electroluminescence element using same | IDEMITSU KOSAN CO., LTD. (JP) | 2018-04-17 | — | — | US | disclosed |
| US-9947879-B2 | Anthracene derivative and organic electroluminescence element using same | IDEMITSU KOSAN CO., LTD. (JP) | 2018-04-17 | — | — | US | disclosed |
| US-20150325800-A1 | ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2015-11-12 | — | — | US | disclosed |
| US-20150325800-A1 | ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2015-11-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180130968-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE | RER1, NR0B1, NR2E1 | CYP1A1 399/4885CYP1B1 341/4885CYP1A2 821/4885 |
| US-20180198077-A1 | ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME | ANXA1, ANXA11, L1CAM | CYP1A1 61/4885CYP1B1 276/4885CYP1A2 252/4885 |
| US-20150325800-A1 | ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME | ANXA1, ANXA11, L1CAM | CYP1A1 61/4885CYP1B1 276/4885CYP1A2 252/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.